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Engineering, Purdue University, West Lafayette, IndianaABSTRACT The aggregation of a-synuclein is thought to play a role in the death of dopamine neurons in Parkinson’s
disease (PD). Alpha-synuclein transitions itself through an aggregation pathway consisting of pathogenic species referred to
as protofibrils (or oligomer), which ultimately convert to mature fibrils. The structural heterogeneity and instability of protofibrils
has significantly impeded advance related to the understanding of their structural characteristics and the amyloid aggregation
mystery. Here, we report, to our knowledge for the first time, on a-synuclein protofibril structural characteristics with cryo-
electron microscopy. Statistical analysis of annular protofibrils revealed a constant wall thickness as a common feature. The
visualization of the assembly steps enabled us to propose a novel, to our knowledge, mechanisms for a-synuclein aggregation
involving ring-opening and protofibril-protofibril interaction events. The ion channel-like protofibrils and their membrane perme-
ability have also been found in other amyloid diseases, suggesting a common molecular mechanism of pathological aggrega-
tion. Our direct visualization of the aggregation pathway of a-synuclein opens up fresh opportunities to advance the
understanding of protein aggregation mechanisms relevant to many amyloid diseases. In turn, this information would enable
the development of additional therapeutic strategies aimed at suppressing toxic protofibrils of amyloid proteins involved in neuro-
logical disorders.INTRODUCTIONParkinson’s disease (PD) affects 1–2% of people over the
age of 60 with a drastic increase of the prevalence of PD
in the following decades (1,2). The aggregation of a-synu-
clein is increasingly believed to play a critical part in the
etiology of PD (3–5). Importantly, the abnormal protein
aggregation characterizes a considerable number of human
diseases, such as Alzheimer’s, Parkinson’s, and Hunting-
ton’s diseases, and type II diabetes (4,6,7). Moreover, the
self-assembly of polypeptides to form amyloid structures
is a common phenomenon that was also found in the
peptides and proteins not related to any amyloid diseases
(8–11). Therefore, information on the a-synuclein aggrega-
tion mechanism would be valuable not only for the under-
standing of PD pathogenesis and the development of
additional therapeutic strategies, but also for related re-
searches of other amyloid diseases and the exploration of
self-assembly phenomena.
Accumulating evidence implies that protofibrils, rather
than mature fibrillar aggregates, may be the pathogenic spe-
cies (12–14). Various forms of a-synuclein protofibrils
including spherical, annular, and chain-like aggregations
have been reported, showing the heterogeneity of pro-
tofibrils (14–16). Among these protofibril structures, the
annular protofibrils aroused great interest. In early in vitro
studies, the annular protofibrils could be formed after pro-
long incubation from heterogeneous spherical protofibrils
with an average height of 2.7 nm, and be observed in mem-Submitted January 9, 2013, and accepted for publication April 23, 2013.
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0006-3495/13/06/2706/8 $2.00brane-associated form (16). PD-linked mutants were found
to promote annular protofibril formation, suggesting a
pore-like mechanism for the toxicity of b-sheet rich annular
protofibrils (16,17). Besides PD (17–19), ion channel-like
annular protofibrils have also been found in other amyloid
diseases, such as Alzheimer’s disease (18–21), prion-related
diseases (22), and type II diabetes (23), suggesting a com-
mon molecular mechanism of aggregation (24,25). How-
ever, details of the protofibril structures and aggregation
pathway of a-synuclein remain poorly understood due to
the structural heterogeneity and instability of protofibrils
(7). From the literature, it is difficult to determine whether
annular protofibrils are on the direct pathway to mature
fibrils and to understand how they finally convert to fibrils.
In addition, with traditional visualization methods such as
AFM and negative stain transmission electron microscopy
(TEM), the structures and sizes of protofibrils observed
were altered from their native state. For instance, the corre-
lation of annular protofibrils and tubular protofibrils was
blurred in negative stain TEM images (17).
The wall thicknesses of annular protofibrils were also
much larger than those calculated with molecular dynamics
simulations (25,26). To characterize the structure of
a-synuclein protofibrils and unravel the aggregation mys-
tery, we used cryo-electron microscopy (cryo-EM) for the
first time, to our knowledge, to study protofibrils in solu-
tions. Upon the measurement of the true size of annular
protofibrils and the visualization of aggregation steps, we
found the correlation of annular protofibrils and fibrils,
and further proposed an aggregation pathway.http://dx.doi.org/10.1016/j.bpj.2013.04.050
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Protein expression and purification
Cells of theE. coli strain BL21 (DE3)were transformedwith the plasmid pT7-
7 wild-type (WT) a-synuclein incubated at 37C in the presence of 1 mM iso-
propylb-D-thiogalactopyranoside to induce protein expression. The cellswere
harvested by centrifugation and resuspended in buffer (10 mM Tris-HCl, pH
8.0, 1 mM EDTA, 1 mM PMSF). The cell suspension was frozen, thawed,
and then lysed with a French pressure cell (psi > 1000) (Thermo Electron,
Waltham, MA). Partial purification of the a-synuclein lysate was achieved by
two successive ammonium sulfate precipitations (30 and 50% saturation) at
4C. The pellet was resuspended in 10 mM Tris-HCl, pH 7.4 and boiled for
5 min. Centrifugation was performed to remove insoluble proteins, and the
supernatant was passed through a 0.22-mm filter and applied to a DEAE Sep-
harose FF column (16  100 mm, Amersham Biosciences, Sunnyvale, CA).
Alpha-synuclein was eluted from the columnwith an increasing concentration
gradient of NaCl. Fractions containing a-synuclein were identified by sodium
dodecyl-sulfate polyacrylamide gel electrophoresis with Coomassie-Blue
staining and pooled, and the resulting protein solution was dialyzed against
10 mM NH4HCO3 for 24 h and lyophilized. The protein was ~95% pure.Fibrillization
WT a-synuclein was reconstituted in 1  phosphate-buffered saline (PBS),
0.02% (w/v) NaN3 and then passed through a 0.22 mm and 100 kDa
molecular-weight cut-off (MWCO) filter. The remaining protein was then
dialyzed in the same buffer for 24 h at 4C. WT a-synuclein (400 mM)
was incubated in the absence and presence of 40 mM copper sulfate
(40 mM) at 37C on a rolling rack. Aliquots were collected at different
time points and stored at 80C.Fourier transform infrared spectroscopy
Attenuated total reflectance (ATR)-Fourier transform infrared (FTIR) spec-
troscopy data were recorded on a Spectrum 100 FTIR spectrometer equip-
ped with a universal ATR sampling accessory (Perkin Elmer, Waltham,
MA). WT a-synuclein solution in the presence of copper sulfate at the in-
cubation time of 60 h was first centrifuged for 5 min at 16,000 RCF and
filtered through a 200-mm filter to eliminate insoluble aggregates. Then
the filtrates were loaded into Ultra-0.5 centrifugal filter devices (MWCO
100 kDa; Amicon, Danvers, MA) to separate the particles based on the
molecular weight. The separated protein solution was spread out and dried
to form a thin film on a Diamond/ZnSe crystal (27,28). Spectrum data were
analyzed with the ORIGINPRO software from OriginLab (Northampton,
MA). Curve-fitting function was used to estimate secondary structure com-
ponents and corresponding percentages according to the peak positions
identified by second derivatives and Fourier self-deconvolution (27–29).Thioflavin T fluorescence
Aliquots (100 mL) of WT a-synuclein (400 mM) and Thioflavin T (ThT)
(100 mM) in the absence and presence of copper sulfate (40 mM) in 1 
PBS, pH7.4, 0.02% NaN3 were pipetted into a 96-well plate. The aggrega-
tion was monitored at 37C using a Gemini EM Fluorescence Microplate
Reader (Molecular Devices, Sunnyvale, CA) with an excitation wavelength
of 440 nm and an emission wavelength of 482 nm. The fluorescence was
measured every 15 min after the 30-s shaking.Transmission electron microscopy image
collection
Cryo-EM specimens were prepared on holey carbon C-flat 2/2 grids (Pro-
tochips, Raleigh, NC) using a Cp3 cryo-plunger (Gatan, Pleasanton, CA).For cryo-negative staining (cryo-NS) test, the grids with samples were
stained by layering on 100 mL aliquots of saturated ammonium molybdate
(pH 7.2) for 1 min, before the grids were blotted (30,31). Negative stain
specimens were applied to glow-discharged, carbon-coated copper grids.
Then grids were rinsed with three drops of PBS and stained by a drop of
1% uranyl acetate. Images were collected on SO-163 films (Kodak,
Rochester, NY) or 4 K charge-coupled device (Gatan) with a CM200
TEM operating at 200 kV (Philips, Amsterdam, Netherlands).Image processing
The EMAN2 software package (National Center for Macromolecular
Imaging, Houston, TX) was used to box particles and generate reference-
free class averages. Due to the structural heterogeneity, the particles could
not be automatically boxed or classified correctly. Therefore, only one
class of particles was boxed manually each time, and this class was then
used to generate a class average with EMAN2. Annular protofibrils were
classified into four groups based on their outer diameters. Sixty particles
from class E, F, and G were randomly selected for diameter measurement,
whereas 20 particles were chosen from class H (only 28 particles in all).
The wall thickness (L) was calculated from L ¼ 1/2  (DoDi) where
Do and Di were the outer and inner diameter pair of each individual ring.
In general, the diameters that provided the smallest wall thickness were
measured to minimize the projection angle problem. Moreover, the rings
were actually imperfect polygons, so the vertices were avoided when
measuring the diameters.RESULTS AND DISCUSSION
Structural features of protofibrils
Cryo-EM was used to monitor the aggregation process and
collect protofibril images at various incubation times. All
cryo-EM images of protofibrils presented here were
collected in presence of Cu2þ at t ¼ 60 h unless otherwise
specified. Copper (II) cation (40 mM) was added into solu-
tions of wild-type (WT) a-synuclein (400 mM) to accelerate
the aggregation and provide sufficient protofibrils for cryo-
EM testing. There were essentially no differences in proto-
fibril structures from 48 h to 60 h incubation time. However,
the aggregation rate varied from batch to batch. Various
structures of protofibrils (including spherical and annular)
and a-synuclein aggregates of different sizes were observed,
which was in agreement with previous reports (Fig. 1, A
and B) (16–18). Generally, the protofibrils could be roughly
sorted into two types, based on their shapes and brightness
of corresponding cryo-EM images: annular protofibrils
with very low brightness (Fig. 1 A), and a-synuclein aggre-
gates that were brighter (Fig. 1 B). In the annular protofibril
images, a large number of particles did not show the central
hole, as a result of different projection angles.
Single particle averaging was applied to analyze the pro-
tofibril structures from cryo-EM images. The reference-
free class average program in the EMAN2 software package
is generally used to classify different views of homogenous
particles. Although we cannot aim to reach similar results
with heterogeneous a-synuclein protofibrils, the program
can still extract their common structural features. A class
of spherical protofibrils with a diameter of ~3 nm wasBiophysical Journal 104(12) 2706–2713
FIGURE 1 Cryo-EM images of heterogeneous
structures of WT a-synuclein. (A and B) Repre-
sentative images of annular protofibrils and a-syn-
uclein aggregates, respectively. (C) Image
showing nontwist fibrils with three different
widths (L1 z 2.5 nm, L2 z 5.4 nm, and L3 z
12 nm). (D–H) Images showing different classes
of protofibrils. The first image of each row repre-
sents a class average calculated from 25 particles
(D), 135 particles (E), 112 particles (F), 143 parti-
cles (G), and 28 particles (H). Each class average
image is followed by seven images consisting of
representative particles from the same class. (I)
Images of typical annular protofibrils demon-
strating polygon structures, together with corre-
sponding cartoons emphasizing the polygon
features. (J) Images of particles in the ring open-
ing step, shown before (top row) or after (middle
row) applying a low-pass filter; (bottom row) cor-
responding cartoons for visualization assistance.
(K) cryo-NS images showing the ring opening
step. (L) Images of laterally aggregated annular
protofibrils. The size of each square box in panels
D–L is 30.5 nm.
FIGURE 2 Statistical analysis of the outer diameter (Do), inner diameter
(Di) and wall thickness (L ¼ 1/2  (DoDi)) of each class of annular pro-
tofibrils (mean5 SD, n¼ 60 in classes E, F, and G; n¼ 20 in class H). The
wall thicknesses (L) of classes E, F, G, and H are 2.325 0.10 nm, 2.425
0.09 nm, 2.405 0.11 nm, and 2.525 0.16 nm, respectively.
2708 Zhang et al.selected from a-synuclein aggregate images (Fig. 1D). Their
sizewas comparable to the structure reported as being able to
convert to annular protofibrils after prolonged incubation
(16). Four classes of particles were selected from annular
aggregate images (Fig. 1, E–H). In Fig. 1, D–H, class aver-
ages are exhibited in the first images of each row, followed
by seven representative particles of corresponding classes.
The molecular weights of annular protofibrils are close to
the imaging resolution limit of cryo-EM (17), making their
low dose cryo-EM images rather noisy; nevertheless, their
shape is still discernible. The generation of clear class
averages supported the existence of these small protofibrils,
and this was also confirmed via negative stain images (see
Fig. S1 in the SupportingMaterial). The significant improve-
ment of contrast in class average images implied the struc-
tural similarity of protofibrils within each class.
Statistical analysis of annular protofibrils revealed that
they had identical wall thickness regardless of their respec-
tive diameters. We classified the annular protofibrils into
four groups, based on their outer diameters. From the class
average images we found that the wall thicknesses of the
rings (set as L) were similar among the four groups. To
confirm this result, the outer and inner diameters (set as
Do and Di, respectively) of the annular protofibrils in each
class were measured and shown in Fig. 2. L calculated
from Do and Di was constant (~2.4 nm) regardless of the
ring diameter. At close inspection, it was revealed that
most of the annular protofibrils actually were not annuli,
but imperfect polygons possessing variable amounts of
straight-protofilament-like subunits. This observation was
in agreement with other reports using AFM or molecular
dynamics simulations as the main investigative methods
(25,26,32). Four typical annular protofibrils with this featureBiophysical Journal 104(12) 2706–2713are shown in Fig. 1 I. Furthermore, ATR-FTIR analysis was
applied to investigate the secondary structure of protofibrils
formed during the incubation. The spectra were decom-
posed, in terms of the peak positions obtained from second
derivatives and Fourier self-deconvolution, by fitting with
Gaussian curves. The protein sample in presence of Cu2þ
at the incubation time of 60 h was separated by centrifugal
filters (MWCO 100 kDa). The particles larger than 100 kDa
displayed widely distributed annular structures in the
negative stain TEM image (Fig. 3 D) and high b-sheet
FIGURE 3 The analysis of the secondary struc-
ture of annular protofibrils. ATR-FTIR spectra of
a-synuclein samples in the fraction of particles
smaller than 100 kDa (A) and the fraction of parti-
cles larger than 100 kDa (B). The experimental
FTIR spectra (black) were decomposed by fitting
with Gaussian curves (green). The cumulative fit
curve was shown (red). Negative stain TEM
images of particles smaller than 100 kDa (C) and
particles larger than 100 kDa (D).
Cryo-EM of a-Synuclein Protofibrils 2709contribution (49.8%) with the peaks at approximately at
1631 cm1 and 1692 cm1 in the FTIR spectrum (Fig. 3
B). On the other hand, no annular structures were observed
in the particles smaller than 100 kDa (Fig. 3 C), which
exhibited much lower b-sheet content (22%) with the peaks
at ~1627 cm1 and 1693 cm1 (Fig. 3 A).
The existence of a large amount of annular protofibrils
coinciding with high b-sheet content suggested that annular
protofibrils were b-sheet-rich structures, which is in agree-
ment with previous reports. Diversified b-sheet-rich amy-
loid protofibrils were reported to transiently form earlier
than fibrils and then disappeared along with fibril formation
(24,33–35). Particularly, the annular protofibrils of the PD
linked mutant A53T and Ab were found to exhibit high
b-sheet content (17,19). The observation of rigid straight-
protofilament-like subunits in this research also supported
that the annular protofibrils were in a b-sheet conformation.
Consequently, we inferred that annular protofibrils of
different diameters appeared to be constructed of small
and nontwisted filamentous structure of z2.4 nm width
that might be equivalent to the protofilament in a mature
fibril (see below).Annular protofibrils and fibrils
Coincidentally, the width of the thinnest fibril (L1) in Fig. 1
C was ~2.5 nm, close to the wall thickness of the annular
protofibrils. The widths of the other two thicker fibrils inFig. 1 C were L2 z 5.4 nm and L3 z 12 nm. One report
that used cryo-NS TEM to image a-synuclein structures
showed that nontwist fibrils of a-synuclein exhibited a
width of 13 5 1 nm and comprised two filaments
ofz5.5 nm width, each of which was composed of two pro-
tofilaments with a width ofz2.0 nm (36). The characteris-
tics of the three types of fibrils in Fig. 1 C showed similar
results. The small differences between our measured values
and previous data might result from variations of the projec-
tion angles and measurement errors. Accordingly, the three
types of fibrils with widths of L1, L2, and L3 in Fig. 1 C
could be attributed to the protofilament, the filament, and
the mature fibril, respectively.The aggregation pathway
At the early stage of the aggregation, no fibrils or identifi-
able protofibrils were observed (Fig. 4, A and B), showing
that only monomers, dimers, or small oligomers, which
were too small to be observed by cryo-EM, existed in the
system. Annular protofibrils were first found at 48 h incuba-
tion time (Fig. 4 C) and were still the dominant species at
t ¼ 56 h in cryo-EM images (Fig. 4 D). Both annular proto-
fibrils and fibrils could be easily found at t¼ 60 h (Fig. 4 E).
Only amyloid fibrils were observed after seven-day incuba-
tion (Fig. 4 F), implying that most of the annular protofibrils
converted to fibrils. This result was in good agreement with
previous reports, which showed that different types ofBiophysical Journal 104(12) 2706–2713
FIGURE 4 Cryo-EM images showing the structures of the aggregates of 400 mM a-synuclein in the presence of 40 mMCu2þ at a series of incubation times
(t): (A) 0 h, (B) 24 h, (C) 48 h, (D) 56 h, (E) 60 h, and (F) 7 days.
2710 Zhang et al.b-sheet rich amyloid protofibrils transiently formed earlier
than fibrils and then disappeared along with fibril formation
(24,33–35). The aggregation of a-synuclein was in general
parallel with the accumulation of b-sheet conformation
monitored by ThT fluorescence (Fig. 5).
How did annular protofibrils convert to fibrils? Given the
foregoing finding that b-sheet-rich annular protofibrils and
protofilaments shared the same width, the conversion from
the former to the latter could be achieved simply by ring
opening. A few of the particles were captured at the exactFIGURE 5 The aggregation kinetics of 400 mM a-synuclein in the
absence and presence of 40 mM Cu2þ monitored with ThT fluorescence.
Biophysical Journal 104(12) 2706–2713transient ring opening moment (Fig. 1, J and K). Once the
rings opened, these structures could already be called proto-
filaments. Short protofibrils similar to the ones identified in
our cryo-EM investigation (and that appeared to consist of
paired, parallel protofilaments) were previously observed
via negative-stain TEM analysis of A53T a-synuclein and
were called tubular protofibrils (17). Our cryo-EM images
showed that the annular protofibrils could form long narrow
rectangles (the first four images of Fig. 1 J) and then trans-
form into two short and parallel protofilaments, which could
be easily identified in cryo-NS images (Fig. 1 K and see the
Supporting Material). This observation suggested that there
was lateral interaction between the two parallel subunits
resembling the interaction between two filaments. Another
clue for elucidating the aggregation mechanism came
from Fig. 1 L, where annular protofibrils aggregated later-
ally. These rings were in very close proximity without
identifiable gaps, similar to the interaction between two pro-
tofilaments within a filament. Through these two types of
interactions, the short protofilaments generated from
annular protofibrils could easily assemble into short fibrils.
The particles in Fig. 6, A and B, were observed to be short
fibrils with two short filaments of z5.9-nm width each.
To show this interesting stage of the aggregation pathway
with better contrast, a very large defocus was used in
Fig. 6, resulting in an apparent size increase. Upon forma-
tion, the short fibrils underwent association (Fig. 6, A and
B) and further connected with one another to form longer
fibrils (Fig. 6 C), and finally they formed mature fibrils
FIGURE 6 Cryo-EM images displaying the
aggregation process from protofibrils to fibrils.
(A and B) Images showing presumably transient
interactions among protofibrils that could be an
early step in the formation of short fibrils. (Arrows)
Clearest examples. (C and D) Images of a short
fibril (C) and mature fibrils (D).
Cryo-EM of a-Synuclein Protofibrils 2711(Fig. 6 D). The capture of the images showing this aggrega-
tion pathway from annular protofibrils to fibrils, in turn sup-
ported the perspective that the annular protofibrils might be
equivalent to protofilaments within fibrils.
Thus, we propose an a-synuclein aggregation pathway
that is mainly based on the capacity of cryo-EM imaging
to capture dynamic processes of proteins in solution
(Fig. 7). At the beginning, the unstructured monomers
convert to a b-sheet conformation and aggregate to small
protofibrils, a transition that would be accelerated by patho-logical factors (7,16). In the next step, the b-sheet rich pro-
tofibrils further aggregate into either annular protofibrils or
protofilaments by extending the b-sheet structure along the
direction perpendicular to b-strands. Generally, the forma-
tion of annular protofibrils should not be favored due to
the instability of the distorted b-sheet structure. At the
same time, the energetically favored protofilaments
assemble into mature fibrils via lateral interactions. How-
ever, factors such as mutations (17), interactions with
bilayer membranes (25), or the exposure to metal ions inFIGURE 7 The proposed aggregation pathway.
Initially, unstructured monomers convert to a
b-sheet structure and form small protofibrils. The
small protofibrils undergo further assembly to
form either annular or linear protofibrils by extend-
ing the b-sheet along the direction perpendicular to
the b-strands. Linear protofibrils assemble into
mature fibrils via lateral interactions (and each
linear protofibril can be identified as a protofila-
ment in the mature fibrillar structure). Annular pro-
tofibrils convert to fibrils through ring opening
followed by interactions among linear protofibrils.
Biophysical Journal 104(12) 2706–2713
2712 Zhang et al.the study described here facilitate the formation of annular
protofibrils. Annular protofibrils might convert to fibrils
through ring opening and subsequent interactions among
linear protofibrils. There was no identifiable difference of
the annular structures between the protein samples in
the presence and absence of Cu2þ (see the Supporting
Material), which might just promote the aggregation
(Fig. 5) (37,38).CONCLUSION
In summary, we characterized the protofibril structures in
solution with fewer artifacts than by using traditional imag-
ing methods, such as AFM and negative-stain TEM. Hence,
we found the correlation of annular protofibrils and fibrils,
for the first time to our knowledge, by measuring their
true sizes and visualizing the aggregation steps. A better
understanding of the aggregation pathway as presented
here yields fresh insight into the pathogenesis of amyloid-
related diseases, and may provide us the opportunity to
develop additional therapeutic strategies to suppress the
formation of toxic species in these disorders.SUPPORTING MATERIAL
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